NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Remember, approval for an uplist is ultimately subject to panel review. As it concerns NWBO, this is not just an issue of meeting a set of listing criteria — which nine times out of ten is generally the case — but rather a more sensitive issue surrounding corporate governance.

In fact, if this were simply a matter of a checklist, they probably wouldn’t need a highly specialized consultant/advisor/lawyer to manage them through the process. They would otherwise just need outside counsel to handle the application.